Edu Butyrose
  • Responsabile scientifico
  • Articoli
    • BARRIERA EPITELIALE INTESTINALE
    • BUTIRRATO
    • COVID-19
    • GVHD – Graft-versus-Host Disease / Malattia del trapianto contro l’ospite
    • IBS
    • IBD
    • IDROSADENITE SUPPURATIVA
    • LINEE GUIDA
    • MALATTIE METABOLICHE
    • MALATTIA DIVERTICOLARE
    • RADIOTERAPIA
    • RIGENERAZIONE CUTANEA
  • Interviste
  • Eventi
  • Studi in corso
  • Riviste
  • Documenti utili
  • LSC
  • SILA
  • Logout
Seleziona una pagina
Use of Sodium Butyrate and Its Microencapsulated Forms in Intestinal Diseases—Current Clinical Approach

Use of Sodium Butyrate and Its Microencapsulated Forms in Intestinal Diseases—Current Clinical Approach

da admin | Ott 2, 2026 | MALATTIA DIVERTICOLARE

Non hai il permesso di visualizzare questo contenuto.
Use of Sodium Butyrate and Its Microencapsulated Forms in Intestinal Diseases—Current Clinical Approach

Overlap of Structural Gastrointestinal Disorders in Children With Disorders of Gut-Brain Interaction

da admin | Ott 2, 2026 | DGBI 2026 DISORDERS GUT BRAIN INTERACTION

Overlap of Structural Gastrointestinal Disorders in Children With Disorders of Gut-Brain Interaction Andrew Krueger, Umber Waheed, Neha Santucci  PubMed Central Visualizza...
Use of Sodium Butyrate and Its Microencapsulated Forms in Intestinal Diseases—Current Clinical Approach

Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study targeting gut microbiota

da admin | Dic 23, 2025 | LETTERATURA BUTYROSE

Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study targeting gut microbiota Sonia Facchin, Matteo Calgaro, Mattia Pandolfo, Andrea Buda, Brigida Barberio, Fabiana Zingone, Nicola Vitulo, Edoardo Vincenzo...
Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease

Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease

da admin | Nov 5, 2025 | LETTERATURA BUTYROSE

Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease Sonia Facchin,  Nicola Vitulo, Matteo Calgaro, Andrea Buda, Chiara Romualdi, Daniel Pohl, Barbara Perini, Greta Lorenzon, Carla Marinelli, Renata D’Incà,...
Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease

The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study

da admin | Nov 5, 2025 | LETTERATURA BUTYROSE

The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study Federico De Blasio, Marta Vernero, Davide Giuseppe Ribaldone Visualizza...
« Post precedenti

Articoli recenti

  • Global guidelines on diverticular disease of the colon: the Fiesole Consensus report
  • Gut microbiota in symptomatic uncomplicated diverticular disease stratifies by severity of abdominal pain
  • Micro-encapsulated and colonic-release sodium butyrate modulates gut microbiota and improves abdominal pain in patients with symptomatic uncomplicated diverticular disease
  • Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis—a prospective randomized study
  • Rifaximin in diverticulosis and diverticular disease: a national survey among Italian gastroenterologists and general practitioners

Commenti recenti

    ideA-Z Project in progress S.r.l. | P.IVA: IT03373190960
    Corso Giacomo Matteotti, 48 – 20081 – Abbiategrasso (MI) | info@idea-z.it